20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP1736L | Fibrinogen-Binding Peptide 137235-80-4(fb-acetate) | Others | |
Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen-Binding Peptide binds fibrinogen and inhibits ... | |||
TP1736 | Fibrinogen-Binding Peptide | ||
Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen, a soluble plasma protein, is a cofactor in pl... | |||
TP1778 | Fibrinogen Binding Inhibitor Peptide | ||
Fibrinogen Binding Inhibitor Peptide, a synthetic dodecapeptide, represents the specific platelet receptor recognition site of the human fibrinogen g-chain (residues 400-411). | |||
T78367 | Fibrinogen (Bovine) | ||
Fibrinogen (Bovine) is a molecule selectively proteolyzed, assembling into a fibrin clot upon thrombin activation [1]. | |||
T80683 | γ-Fibrinogen 377-395 | ||
γ-Fibrinogen377-395 is a peptide derived from fibrinogen, functioning both as an inhibitory molecule and an epitope. It inhibits microglial activation, disrupts fibrin-Mac-1 interactions in vitro, and mitigates experimen... | |||
T80682 | γ-Fibrinogen 377-395 TFA | ||
γ-Fibrinogen377-395 TFA is an inhibitory peptide derived from fibrinogen, which also functions as a fibrinogen epitope. It effectively blocks microglial activation and impedes fibrin-Mac-1 interactions in vitro. Addition... | |||
TP1060 | GPRP acetate (67869-62-9 free base) | Pefabloc FG,Pefa 6003,GPRP acetate | Others |
GPRP acetate (Pefabloc FG) is fibrinogen-related peptides, which inhibit the interaction of fibrinogen with the platelet membrane glycoprotein IIbIIIa complex (GPIIbIIIa). | |||
T40711 | H-D-Phe-Pip-Arg-pNA dihydrochloride | S-2238 dihydrochloride,H-D-Phe-Pip-Arg-pNA dihydrochloride | Others |
H-D-Phe-Pip-Arg-pNA dihydrochloride (S-2238 dihydrochloride), a chromogenic substrate, mimics the N-terminal fragment of the A alpha chain of fibrinogen, the native substrate of thrombin. Specifically designed for thromb... | |||
T12857 | SC-52012 | Others | |
SC-52012 is a novel and potent fibrinogen receptor antagonist, an RGD mimetic, which inhibits platelet aggregation. | |||
TP1143L | Fibrinopeptide A, human acetate | Fibrinopeptide A, human acetate(25422-31-5 free base),Human fibrinopeptide A acetate | Others |
Fibrinopeptide A, human acetate (Human fibrinopeptide A acetate) is a 16-residue short polypeptide cleaved from fibrinogen by thrombin. Fibrinopeptide A (FPA) is produced from the N-terminal Aα region of fibrinogen prote... | |||
TP1447L1 | Arg-Gly-Asp-Cys acetate | Arg-Gly-Asp-Cys acetate(109292-46-8 free base),RGDC acetate | Others |
Arg-Gly-Asp-Cys acetate inhibits platelet aggregation and fibrinogen binding. Arg-Gly-Asp-Cys acetate is the binding motif of fibronectin to cell adhesion molecules. | |||
T3793 | (20R)-Ginsenoside Rh1 | 20(R)-Ginsenoside Rh1 | Others |
(20R)-Ginsenoside Rh1 (20(R)-Ginsenoside Rh1) can inhibit the thrombin-induced conversion of fibrinogen to fibrin. | |||
TP1458L | Arg-Gly-Glu-Ser acetate(93674-97-6 free base) | Others | |
Arg-Gly-Glu-Ser acetate is a RGD related peptide that is a control for the RGDS activity of fibrinogen binding to activated platelets. | |||
T5519 | Bivalirudin | BG-8967,Hirulog-1 | Thrombin |
Bivalirudin (BG-8967) is a reversible inhibitor of α- and ζ-thrombin (Kis = 2.56 and 1.84 nM, respectively), enzymes that exhibit high fibrinogen-clotting activities. | |||
T3638 | Leukadherin-1 | Integrin , Complement System | |
Leukadherin-1 is an allosteric activator of CD11b/CD18. Increasing CD11b/CD18-dependent cell adhesion to fibrinogen, Decreasing leukocyte motility and transendothelial migration; reduces inflammation. | |||
T0182L | Clopidogrel hydrogen sulfate | (S)-(+)-Clopidogrel hydrogen sulfate,(S)-(+)-Clopidogrel bisulfate,SR-25990C,Clopidogrel | P450 , P2Y Receptor |
Clopidogrel hydrogen sulfate ((S)-(+)-Clopidogrel bisulfate) , a selective, high-affinity P2Y12 receptor antagonist, suppressess fibrinogen binding to platelets and platelet adhesion and aggregation. | |||
T26629 | Angstrom6 | A-6,A 6 peptide,A6,A 6,A6 peptide,A-6 peptide | PAI-1 |
Angstrom6 (A-6 peptide) is an 8 amino acid peptide derived from single chain urokinase fibrinogen activator (scuPA) that interferes with the uPA/uPAR cascade and abrogates the downstream effects.Angstrom6 has antitumor a... | |||
T22807 | GR 144053 trihydrochloride | Others | |
platelet fibrinogen receptor glycoprotein IIb/IIIa (GpIIb/IIIa) antagonist | |||
T24347 | L 703014 | L 703,014,L-703014,L703,014,L-703,014,L703014 | |
L 703014 is an antagonist of the fibrinogen receptor. | |||
T24290 | L 366763 | L366,763,L-366,763,L-366763,L366763,L 366,763 | |
L 366763 is an antagonist of the peptidyl fibrinogen receptor. |